Skip to main content
. 2005 Jan 25;92(3):459–466. doi: 10.1038/sj.bjc.6602342

Table 3. Therapeutic management over time.

  1982–85
1986–89
1990–93
1994–97
 
Period No. % No. % No. % No. % P
Resectable disease                  
 Radiotherapya 44 24.4 35 17.9 26 12.7 23 11.4 0.0023
 Surgerya 60 33.3 99 50.5 108 52.9 112 55.4 <0.0001
 Chemotherapy 2 1.1 2 1.0 5 2.5 6 3.0 0.4290
 Surgery+radiotherapy 31 17.2 41 20.9 34 16.7 24 11.9 0.1149
 Surgery+chemotherapy 11 6.1 5 2.6 6 2.9 8 4.0 0.2777
 Chemotherapy+radiotherapy 13 7.2 1 0.5 2 1.0 8 4.0 0.0004
 Surgery+radio+chemotherapy 8 4.4 3 1.5 11 5.4 10 5.0 0.2043
 Supportive care 11 6.1 10 5.1 12 5.9 11 5.4 0.9745
                   
Locally advanced disease                  
 Radiotherapya 28 53.8 49 70.0 39 40.6 12 12.9 <0.0001
 Chemotherapy 7 13.5 3 4.3 12 12.5 11 11.8 0.2720
 Chemotherapy+surgery 0 0.0 0 0.0 0 0.0 2 2.2 0.2419
 Chemo+radiotherapya 11 21.2 9 12.9 29 30.2 55 59.1 <0.0001
 Chemo+surgery+radiotherapy 0 0.0 3 4.3 6 6.3 4 4.3 0.3247
 Supportive care 6 11.5 6 8.6 10 10.4 9 9.7 0.9552
                   
Metastatic disease                  
 Radiotherapya 28 31.1 30 24.6 17 11.5 8 4.6 <0.0001
 Chemotherapya 24 26.7 32 26.2 64 43.2 113 65.3 <0.0001
 Chemotherapy+surgery 0 0.0 1 0.8 1 0.7 2 1.2 0.9155
 Chemo+radiotherapya 17 18.9 4 3.3 15 10.1 10 5.8 0.0003
 Surgery 0 0.0 0 0.0 1 0.7 0 0.0 0.6754
 Chemo+radiotherapy+surgery 0 0.0 0 0.0 0 0.0 1 0.6 0.9999
 Supportive care 21 23.3 55 45.1 50 33.8 39 22.5 0.0002
a

Linear trend significant